What does an eosinophil (white blood cell) percentage of 11.8% indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

An eosinophil percentage of 11.8% is not directly indicative of eosinophilic oesophagitis (EoE) as the diagnosis of EoE requires a combination of clinical, endoscopic, and histological features, including an eosinophil count of >15 eosinophils per 0.3 mm2 in any biopsy specimen 1.

Understanding Eosinophil Percentage

Eosinophil percentage is a measure that can indicate various conditions, but in the context of eosinophilic oesophagitis, the focus is on the absolute eosinophil count per high power field (hpf) rather than the percentage.

  • The normal range for eosinophil percentage in blood tests is typically considered to be 0-6% of total white blood cells, but this can vary slightly by laboratory.
  • An elevated eosinophil percentage, such as 11.8%, suggests eosinophilia, which can be associated with several conditions including allergic reactions, parasitic infections, autoimmune disorders, or medication reactions.

Diagnosis of Eosinophilic Oesophagitis

The diagnosis of EoE is based on a combination of clinical symptoms (such as dysphagia, food impaction, and abdominal pain), endoscopic findings (like esophageal rings, furrows, and white exudates), and histological evidence of eosinophilic infiltration 1.

  • Histologically, a diagnosis of EoE is supported by an eosinophil count of >15 eosinophils per 0.3 mm2 in any biopsy specimen, along with other features such as basal cell hyperplasia, eosinophil microabscesses, and subepithelial sclerosis 1.
  • The percentage of eosinophils in the blood or tissue does not directly correlate with the diagnosis of EoE; instead, the absolute count of eosinophils per high power field is crucial.

Clinical Implications

Given the information provided, an eosinophil percentage of 11.8% would prompt further investigation to determine the underlying cause of eosinophilia, which could include:

  • Complete blood count with differential to assess the absolute eosinophil count.
  • Stool examination for parasites.
  • Allergy testing.
  • Endoscopy with biopsies if EoE is suspected, based on clinical presentation and other diagnostic criteria. It's essential to consult with a healthcare provider for a comprehensive evaluation and appropriate management based on the underlying cause of the elevated eosinophil percentage.

From the Research

Eosinophil Percentage

  • An eosinophil percentage of 11.8% is considered elevated, as the normal range for eosinophils is typically between 1-4% of the total white blood cell count 2.
  • Eosinophilia, which is defined as an elevation of eosinophils in the bloodstream, can be caused by a variety of factors, including parasitic disease, allergic disease, autoimmune disease, and malignant states 2.

Possible Causes

  • The causes of eosinophilia can be broadly categorized into primary (clonal) and secondary (reactive) eosinophilia 3.
  • Primary eosinophilia includes conditions such as hypereosinophilic syndrome, while secondary eosinophilia can be caused by factors such as parasitic infections, allergic reactions, and autoimmune disorders 3.

Diagnostic Evaluation

  • Diagnostic evaluation of eosinophilia typically involves a combination of morphologic review of the blood and marrow, standard cytogenetics, fluorescence in situ hybridization, next-generation sequencing gene assays, and flow immunophenotyping 3.
  • The goal of diagnostic evaluation is to identify the underlying cause of eosinophilia and to determine the appropriate course of treatment 3.

Treatment Options

  • Treatment options for eosinophilia depend on the underlying cause and may include medications such as corticosteroids, hydroxyurea, and interferon-α 3, 4.
  • In some cases, biologic therapies such as mepolizumab and benralizumab may be used to target specific pathways involved in eosinophilia 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.